Brexpiprazole (Rexulti)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Brexpiprazole (Rexulti), covering 2016-03-15 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia [Phase 3]